NCT02699892View on ClinicalTrials.gov

Study to Examine Efficacy and Safety of Rituximab in Participants With Rheumatoid Arthritis

CompletedOBSERVATIONAL

Enrollment

130

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions

Rheumatoid Arthritis

Interventions

DRUG

Rituximab

Rituximab will be administered at the discretion of treating physician according to approved label. Protocol does not specify/enforce the criteria for initiation of treatment with rituximab and procedure of the infusion of rituximab.

Trial Locations (4)

11000

Belgrade

18250

Niška Banja

21000

Nova Sad

Novi Sad

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT02699892 - Study to Examine Efficacy and Safety of Rituximab in Participants With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter